Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling

Carlo G. Tocchetti, Wang Wang, Jeffrey P. Froehlich, Sabine Huke, Miguel A. Aon, Gerald M. Wilson, Giulietta Di Benedetto, Brian O'Rourke, Wei Dong Gao, David A. Wink, John P. Toscano, Manuela Zaccolo, Donald M Bers, Hector H. Valdivia, Heping Cheng, David A. Kass, Nazareno Paolocci

Research output: Contribution to journalArticle

160 Citations (Scopus)

Abstract

Heart failure remains a leading cause of morbidity and mortality worldwide. Although depressed pump function is common, development of effective therapies to stimulate contraction has proven difficult. This is thought to be attributable to their frequent reliance on cAMP stimulation to increase activator Ca. A potential alternative is nitroxyl (HNO), the 1-electron reduction product of nitric oxide (NO) that improves contraction and relaxation in normal and failing hearts in vivo. The mechanism for myocyte effects remains unknown. Here, we show that this activity results from a direct interaction of HNO with the sarcoplasmic reticulum Ca pump and the ryanodine receptor 2, leading to increased Ca uptake and release from the sarcoplasmic reticulum. HNO increases the open probability of isolated ryanodine-sensitive Ca-release channels and accelerates Ca reuptake into isolated sarcoplasmic reticulum by stimulating ATP-dependent Ca transport. Contraction improves with no net rise in diastolic calcium. These changes are not induced by NO, are fully reversible by addition of reducing agents (redox sensitive), and independent of both cAMP/protein kinase A and cGMP/protein kinase G signaling. Rather, the data support HNO/thiolate interactions that enhance the activity of intracellular Ca cycling proteins. These findings suggest HNO donors are attractive candidates for the pharmacological treatment of heart failure.

Original languageEnglish (US)
Pages (from-to)96-104
Number of pages9
JournalCirculation Research
Volume100
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Sarcoplasmic Reticulum
Nitric Oxide
Heart Failure
Cyclic GMP-Dependent Protein Kinases
Ryanodine
Ryanodine Receptor Calcium Release Channel
Reducing Agents
Cyclic AMP-Dependent Protein Kinases
Treatment Failure
Muscle Cells
Oxidation-Reduction
Adenosine Triphosphate
Pharmacology
Electrons
Calcium
Morbidity
Mortality
nitroxyl
Proteins
Therapeutics

Keywords

  • Contractility
  • Excitation/contraction coupling
  • Nitroxyl
  • Ryanodine receptor
  • Sarcoplasmic reticulum Ca -ATPase

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Tocchetti, C. G., Wang, W., Froehlich, J. P., Huke, S., Aon, M. A., Wilson, G. M., ... Paolocci, N. (2007). Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circulation Research, 100(1), 96-104. https://doi.org/10.1161/01.RES.0000253904.53601.c9

Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. / Tocchetti, Carlo G.; Wang, Wang; Froehlich, Jeffrey P.; Huke, Sabine; Aon, Miguel A.; Wilson, Gerald M.; Di Benedetto, Giulietta; O'Rourke, Brian; Gao, Wei Dong; Wink, David A.; Toscano, John P.; Zaccolo, Manuela; Bers, Donald M; Valdivia, Hector H.; Cheng, Heping; Kass, David A.; Paolocci, Nazareno.

In: Circulation Research, Vol. 100, No. 1, 01.2007, p. 96-104.

Research output: Contribution to journalArticle

Tocchetti, CG, Wang, W, Froehlich, JP, Huke, S, Aon, MA, Wilson, GM, Di Benedetto, G, O'Rourke, B, Gao, WD, Wink, DA, Toscano, JP, Zaccolo, M, Bers, DM, Valdivia, HH, Cheng, H, Kass, DA & Paolocci, N 2007, 'Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling', Circulation Research, vol. 100, no. 1, pp. 96-104. https://doi.org/10.1161/01.RES.0000253904.53601.c9
Tocchetti, Carlo G. ; Wang, Wang ; Froehlich, Jeffrey P. ; Huke, Sabine ; Aon, Miguel A. ; Wilson, Gerald M. ; Di Benedetto, Giulietta ; O'Rourke, Brian ; Gao, Wei Dong ; Wink, David A. ; Toscano, John P. ; Zaccolo, Manuela ; Bers, Donald M ; Valdivia, Hector H. ; Cheng, Heping ; Kass, David A. ; Paolocci, Nazareno. / Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. In: Circulation Research. 2007 ; Vol. 100, No. 1. pp. 96-104.
@article{48efb26008b645a583bfe3c2c20ed5ad,
title = "Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling",
abstract = "Heart failure remains a leading cause of morbidity and mortality worldwide. Although depressed pump function is common, development of effective therapies to stimulate contraction has proven difficult. This is thought to be attributable to their frequent reliance on cAMP stimulation to increase activator Ca. A potential alternative is nitroxyl (HNO), the 1-electron reduction product of nitric oxide (NO) that improves contraction and relaxation in normal and failing hearts in vivo. The mechanism for myocyte effects remains unknown. Here, we show that this activity results from a direct interaction of HNO with the sarcoplasmic reticulum Ca pump and the ryanodine receptor 2, leading to increased Ca uptake and release from the sarcoplasmic reticulum. HNO increases the open probability of isolated ryanodine-sensitive Ca-release channels and accelerates Ca reuptake into isolated sarcoplasmic reticulum by stimulating ATP-dependent Ca transport. Contraction improves with no net rise in diastolic calcium. These changes are not induced by NO, are fully reversible by addition of reducing agents (redox sensitive), and independent of both cAMP/protein kinase A and cGMP/protein kinase G signaling. Rather, the data support HNO/thiolate interactions that enhance the activity of intracellular Ca cycling proteins. These findings suggest HNO donors are attractive candidates for the pharmacological treatment of heart failure.",
keywords = "Contractility, Excitation/contraction coupling, Nitroxyl, Ryanodine receptor, Sarcoplasmic reticulum Ca -ATPase",
author = "Tocchetti, {Carlo G.} and Wang Wang and Froehlich, {Jeffrey P.} and Sabine Huke and Aon, {Miguel A.} and Wilson, {Gerald M.} and {Di Benedetto}, Giulietta and Brian O'Rourke and Gao, {Wei Dong} and Wink, {David A.} and Toscano, {John P.} and Manuela Zaccolo and Bers, {Donald M} and Valdivia, {Hector H.} and Heping Cheng and Kass, {David A.} and Nazareno Paolocci",
year = "2007",
month = "1",
doi = "10.1161/01.RES.0000253904.53601.c9",
language = "English (US)",
volume = "100",
pages = "96--104",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling

AU - Tocchetti, Carlo G.

AU - Wang, Wang

AU - Froehlich, Jeffrey P.

AU - Huke, Sabine

AU - Aon, Miguel A.

AU - Wilson, Gerald M.

AU - Di Benedetto, Giulietta

AU - O'Rourke, Brian

AU - Gao, Wei Dong

AU - Wink, David A.

AU - Toscano, John P.

AU - Zaccolo, Manuela

AU - Bers, Donald M

AU - Valdivia, Hector H.

AU - Cheng, Heping

AU - Kass, David A.

AU - Paolocci, Nazareno

PY - 2007/1

Y1 - 2007/1

N2 - Heart failure remains a leading cause of morbidity and mortality worldwide. Although depressed pump function is common, development of effective therapies to stimulate contraction has proven difficult. This is thought to be attributable to their frequent reliance on cAMP stimulation to increase activator Ca. A potential alternative is nitroxyl (HNO), the 1-electron reduction product of nitric oxide (NO) that improves contraction and relaxation in normal and failing hearts in vivo. The mechanism for myocyte effects remains unknown. Here, we show that this activity results from a direct interaction of HNO with the sarcoplasmic reticulum Ca pump and the ryanodine receptor 2, leading to increased Ca uptake and release from the sarcoplasmic reticulum. HNO increases the open probability of isolated ryanodine-sensitive Ca-release channels and accelerates Ca reuptake into isolated sarcoplasmic reticulum by stimulating ATP-dependent Ca transport. Contraction improves with no net rise in diastolic calcium. These changes are not induced by NO, are fully reversible by addition of reducing agents (redox sensitive), and independent of both cAMP/protein kinase A and cGMP/protein kinase G signaling. Rather, the data support HNO/thiolate interactions that enhance the activity of intracellular Ca cycling proteins. These findings suggest HNO donors are attractive candidates for the pharmacological treatment of heart failure.

AB - Heart failure remains a leading cause of morbidity and mortality worldwide. Although depressed pump function is common, development of effective therapies to stimulate contraction has proven difficult. This is thought to be attributable to their frequent reliance on cAMP stimulation to increase activator Ca. A potential alternative is nitroxyl (HNO), the 1-electron reduction product of nitric oxide (NO) that improves contraction and relaxation in normal and failing hearts in vivo. The mechanism for myocyte effects remains unknown. Here, we show that this activity results from a direct interaction of HNO with the sarcoplasmic reticulum Ca pump and the ryanodine receptor 2, leading to increased Ca uptake and release from the sarcoplasmic reticulum. HNO increases the open probability of isolated ryanodine-sensitive Ca-release channels and accelerates Ca reuptake into isolated sarcoplasmic reticulum by stimulating ATP-dependent Ca transport. Contraction improves with no net rise in diastolic calcium. These changes are not induced by NO, are fully reversible by addition of reducing agents (redox sensitive), and independent of both cAMP/protein kinase A and cGMP/protein kinase G signaling. Rather, the data support HNO/thiolate interactions that enhance the activity of intracellular Ca cycling proteins. These findings suggest HNO donors are attractive candidates for the pharmacological treatment of heart failure.

KW - Contractility

KW - Excitation/contraction coupling

KW - Nitroxyl

KW - Ryanodine receptor

KW - Sarcoplasmic reticulum Ca -ATPase

UR - http://www.scopus.com/inward/record.url?scp=33846035704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846035704&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000253904.53601.c9

DO - 10.1161/01.RES.0000253904.53601.c9

M3 - Article

C2 - 17138943

AN - SCOPUS:33846035704

VL - 100

SP - 96

EP - 104

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 1

ER -